About Index Trending news
Analyze
Pricing
Kerecis

Kerecis

Work at Kerecis? Add yourself to this profile

Kerecis

Kerecis is a developer of patent-pending MariGen™, an omega3 fish-skin acellular dermal matrix transplantation technology.
Edit Profile
More info

Elsewhere

Companies in the same industry

Biolase Biolase EasySense EasySense CALCIVIS LIMITED CALCIVIS LIMITED XACT Robotics XACT Robotics Gauss Surgical Gauss Surgical CliniCloud CliniCloud Fimmic Fimmic BAROnova BAROnova Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc. Hologic Hologic

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Latest funding
Venture capital (Series A)
$2,000,000
NSA Ventures
Seed fund
NSA Ventures
Employees

Team size

10+
Locations
Unknown
Help us complete this profile

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Kerecis makes some noise.